Overview

Antenatal Corticoid Therapy for Late Preterm Babies

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study aims to determine the effectiveness of antenatal corticosteroid therapy in late preterm babies. The investigators hypothesis is corticoid accelerates fetal lung maturation even after 34 weeks and reduces risk of respiratory distress syndrome and other neonatal morbidities.
Phase:
N/A
Details
Lead Sponsor:
Instituto Materno Infantil Prof. Fernando Figueira
Treatments:
Betamethasone
Betamethasone acetate phosphate
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate